Evidence map›Paper›PMID 34920696›Full record

ArticleHuman vaccines & immunotherapeutics2021

Knowledge, beliefs, and acceptability of people toward new COVID-19 vaccines: a pilot study.

Amjad Alfaleh, Abdullah Alkattan, Nashwa Radwan, Nagla Mahmoud, Alaa Alageel, Wedad Alanezi, Khaled Alabdulkareem

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amjad AlfalehResearch Department, General Directorate of School Health, Ministry of Health, Riyadh, Saudi Arabia.ORCID 0000-0003-4375-8834
Abdullah AlkattanResearch Department, General Directorate of School Health, Ministry of Health, Riyadh, Saudi Arabia.ORCID 0000-0001-5294-8088
Nashwa RadwanDepartment of Public Health and Community Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.
Nagla MahmoudDepartment of Research, Assisting Deputyship for Primary Health Care, Ministry of Health, Riyadh, Saudi Arabia.
Alaa AlageelDepartment of Development and Innovation, General Directorate of School Health, Ministry of Health, Riyadh, Saudi Arabia.
Wedad AlaneziDepartment of Development and Innovation, General Directorate of School Health, Ministry of Health, Riyadh, Saudi Arabia.
Khaled AlabdulkareemDepartment of Research, Assisting Deputyship for Primary Health Care, Ministry of Health, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cross-section pilot study was done to determine the knowledge and belief toward new COVID-19 vaccines among a small sample size group of people. A new Vaccine Acceptability Questionnaire (VAQ) consists of 31 questions that were concerned about three elements: underlying factors, knowledge, and beliefs. The study included 96 people from the different regions of Saudi Arabia who had accepted to participate in this pilot study. Around 31% of the included people had low to very low acceptability toward COVID-19 vaccines; however, the other 69% had moderate to high acceptability. The new simple designed questionnaire (VAQ) could be effective in assessing knowledge, beliefs, and acceptability toward COVID-19 vaccination among a specific group of population.

Indexed as

COVID-19COVID-19 VaccinesHumansPilot ProjectsSARS-CoV-2VaccinationCOVID-19 VaccinesacceptabilitybeliefsCOVID-19knowledgeVaccine

Identifiers

PMID34920696
PMCPMC8904014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.